Evidence map›Paper›PMID 25120128›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2014

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Stephen M Hatfield, Jorgen Kjaergaard, Dmitriy Lukashev, Bryan Belikoff, Taylor H Schreiber, Shalini Sethumadhavan, Robert Abbott, Phaethon Philbrook, Molly Thayer, Dai Shujia and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 198 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Tumor hypoxia shapes natural killer cell anticancer activities.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  15. Insights from Clinical Trials on AACS pharmacology & translational science · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Stephen M HatfieldNew England Inflammation and Tissue Protection Institute, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA, s.hatfield@neu.edu.
Jorgen Kjaergaard
Dmitriy Lukashev
Bryan Belikoff
Taylor H Schreiber
Shalini Sethumadhavan
Robert Abbott
Phaethon Philbrook
Molly Thayer
Dai Shujia
Scott Rodig
Jeffrey L Kutok
Jin Ren
Akio Ohta
Eckhard R Podack
Barry Karger
Edwin K Jackson
Michail Sitkovsky
Northeastern University · USHarvard University · USUniversity of Miami · USUniversity of Pittsburgh · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Cancer Immunotherapy by Targeting A2 Adenosine ReceptorR01CA111985 · NCI · NORTHEASTERN UNIVERSITY · PI SITKOVSKY, MICHAIL · 2006 to 2016
$2.7M
Mechanisms of Tumor Protection for T Cells by HypoxiaR01CA112561 · NCI · NORTHEASTERN UNIVERSITY · PI SITKOVSKY, MICHAIL · 2005 to 2009
$1.5M
Adenosine and Oxygen Modulate Antimicrobial DefensesR01GM097320 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G., SITKOVSKY, MICHAIL · 2011 to 2014
$1.2M
Hyperbaric Oxygenation May Increase Lung InjuryR21AT002788 · NCCIH · NORTHEASTERN UNIVERSITY · PI SITKOVSKY, MICHAIL · 2006 to 2007
$387k
NCCIH NIH HHS R21 AT002788NCCIH NIH HHS R21AT 002788NCI NIH HHS R01 CA-111985NCI NIH HHS R01 CA111985NCI NIH HHS R01 CA-112561NCI NIH HHS R01 CA112561NIDDK NIH HHS P30 DK079307NIGMS NIH HHS R01GM-097320
6 · The paper itself

Abstract

unlabelledIntratumoral hypoxia and hypoxia inducible factor-1α (HIF-1-α)-dependent CD39/CD73 ectoenzymes may govern the accumulation of tumor-protecting extracellular adenosine and signaling through A2A adenosine receptors (A2AR) in tumor microenvironments (TME). Here, we explored the conceptually novel motivation to use supplemental oxygen as a treatment to inhibit the hypoxia/HIF-1α-CD39/CD73-driven accumulation of extracellular adenosine in the TME in order to weaken the tumor protection. We report that hyperoxic breathing (60 % O2) decreased the TME hypoxia, as well as levels of HIF-1α and downstream target proteins of HIF-1α in the TME according to proteomic studies in mice. Importantly, oxygenation also downregulated the expression of adenosine-generating ectoenzymes and significantly lowered levels of tumor-protecting extracellular adenosine in the TME. Using supplemental oxygen as a tool in studies of the TME, we also identified FHL-1 as a potentially useful marker for the conversion of hypoxic into normoxic TME. Hyperoxic breathing resulted in the upregulation of antigen-presenting MHC class I molecules on tumor cells and in the better recognition and increased susceptibility to killing by tumor-reactive cytotoxic T cells. Therapeutic breathing of 60 % oxygen resulted in the significant inhibition of growth of established B16.F10 melanoma tumors and prolonged survival of mice. Taken together, the data presented here provide proof-of principle for the therapeutic potential of systemic oxygenation to convert the hypoxic, adenosine-rich and tumor-protecting TME into a normoxic and extracellular adenosine-poor TME that, in turn, may facilitate tumor regression. We propose to explore the combination of supplemental oxygen with existing immunotherapies of cancer. KEY MESSAGES: Oxygenation decreases levels of tumor protecting hypoxia. Oxygenation decreases levels of tumor protecting extracellular adenosine. Oxygenation decreases expression of HIF-1alpha dependent tumor-protecting proteins. Oxygenation increases MHC class I expression and enables tumor regression.

Indexed as

AdenosineAnimalsCell HypoxiaCell Line, TumorFemaleHypoxiaHypoxia-Inducible Factor 1, alpha SubunitMice, Inbred C57BLNeoplasmsOxygenTumor MicroenvironmentAdenosineHypoxia-Inducible Factor 1, alpha SubunitOxygen

Identifiers

PMID25120128
PMCPMC4247798
OpenAlexW2054661897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.